Caladrius Biosciences IncCLBS 35.25% climbed 44.6 percent to $9.5601. Caladrius Biosciences shares climbed over 67 percent Tuesday after announcing the company’s CD34+ cell therapy program received FDA regenerative medicine advanced therapy designation for treating refractory angina.
ADOMANI, Inc. ADOM 41.5%rose 25.2 percent to $1.41 following last night’s PR that the company will enter U.S. electric truck market.
CLPS IncorporationCLPS 23.29% rose 22.4 percent to $13.17 after the company released a letter to shareholders. The China-based company said it’s working on “enhancing its original financial technology service offerings to expand to international markets, serve international customers, and provide innovative solutions and products to support more world-class technology customers.”
Naked Brand Group IncNAKD 552.82% shares gained 18.5 percent to $7.37. Naked Brand and Bendon Limited reported that they have completed their earlier announced merger.
Neptune Technologies & Bioressources Inc.NEPT 14.24% climbed 16.4 percent to $3.76 after surging 31.84 percent on Tuesday.
Intelsat S.A.I 22.98% shares climbed 15.4 percent to $18.53 after falling 2.78 percent on Tuesday. RBC Capital upgraded Intelsat from Sector Perform to Outperform.
Eidos Therapeutics, Inc.EIDX 41.98% gained 14.7 percent to $19.50. Eidos Therapeutics priced its IPO at $17 per share.
New Age Beverages CorporationNBEV 15.38% rose 13 percent to $2.35.
Sangamo Therapeutics, Inc. SGMO 9.96%rose 12.9 percent to $18.575. Bank of America initiated coverage on Sangamo Therapeutics with a Buy rating and a $24 price target.
Synaptics Incorporated .SYNA 12.24% surged 11.6 percent to $54.495 in reaction to M&A news. The company designs technologies to bring innovative and intuitive user experiences to intelligent devices and confirmed Tuesday afternoon it is in talks to sell itself to Dialog Semiconductor.
Apollo Endosurgery, Inc. APEN 14.64%rose 11.6 percent to $6.25. Apollo Endosurgery priced its 3.747 million share offering at $5.50 per share.
Moleculin Biotech, Inc. MBRX 11.94%rose 11.6 percent to $2.2431. The clinical stage pharmaceutical company that develops oncology drug candidates said it received approval from the Polish National Office to begin a phase 1/2 clinical trial of its Annamycin for the treatment of relapsed or refractory acute myeloid leukemia.
TPI Composites, Inc. TPIC 11.35%climbed 11.5 percent to $28.77.
Winnebago Industries, Inc.WGO 13.01% shares gained 11.3 percent to $44.90 after the company reported stronger-than-expected results for its third quarter.
Audentes Therapeutics, Inc. BOLD 7.34%rose 11.2 percent to $45.42.
RumbleON, Inc. RMBL 0.33%rose 11 percent to $6.65.
Tesaro, Inc.TSRO 14.72% shares gained 10.5 percent to $44.19.
Navigator Holdings Ltd. NVGS 9.41%shares rose 9.9 percent to $12.25.
STAAR Surgical Company STAA 11.22%climbed 9.7 percent to $32.250 after the company reported the resolution of FDA Warning Letter.
Nortech Systems IncorporatedNSYS 0.01% rose 8.4 percent to $3.50.
H. Glatfelter CompanyGLT 9.03% climbed 7 percent to $19.66. DA Davidson upgraded P. H. Glatfelter from Neutral to Buy.
HUYA Inc.HUYA 0.28% gained 6.3 percent to $45.415 after dropping 12.04 percent on Tuesday.
Workhorse Group Inc. WKHS 4.34%rose 6.3 percent to $2.12. B. Riley FBR initiated coverage on Workhorse with a Buy rating.
Teligent, Inc. TLGT 0.27%gained 6.2 percent to $3.93 after the company reported the FDA approval of Fluocinonide gel, 0.05%.
Anika Therapeutics IncANIK 37.11% shares dipped 35 percent to $30.00 after reporting top-line results from CINGAL 16-02 clinical trial in knee osteoarthritis study did not achieve statistical significance at primary endpoint.
Astrotech Corporation ASTC 24.22%dipped 23.1 percent to $4.89. Astrotech shares surged 217.44 percent Tuesday after the company’s subsidiary, 1st Detect, announced its TRACER 1000 Explosives Trace Detector was accepted into the European Evaluation Process for airport checkpoint screening.
ReShape Lifesciences Inc. RSLS 21.5%declined 19.8 percent to $2.60 after reporting a $1.5 million registered direct offering priced at-the-market.
Gevo, Inc.GEVO 31.08% shares dropped 18.2 percent to $15.96 after surging 53.54 percent on Tuesday.
Solid Biosciences Inc. SLDB 18.33%fell 16.2 percent to $36.04.
Apollo Medical Holdings, Inc. AMEH 17.35%declined 15.8 percent to $20.50.
Catabasis Pharmaceuticals, Inc. CATB 13.02%fell 15.4 percent to $0.8626 after the company reported pricing of its $42 million underwritten public offering.
Kazia Therapeutics Limited KZIA 17.72%dropped 13.5 percent to $3.7390.
HomeTown Bankshares CorporationHMTA 8.93% shares fell 11 percent to $13.35.
Galectin Therapeutics, Inc. GALT 11.28%slipped 9.2 percent to $8.13.
com Holdings, Inc. ALRM 9.66%fell 7.9 percent to $41.73.
Starbucks CorporationSBUX 8.48% shares fell 7.5 percent to $53.16 after announcing weak third-quarter guidance and the closing of 150 stores.
Oracle CorporationORCL 7.76% shares fell 6.2 percent to $43.410. Oracle reported better-than-expected earnings for its fourth quarter, but issued weak guidance for the first quarter.
La-Z-Boy IncorporatedLZB 2.41% shares fell 4 percent to $31.95. La-Z-Boy reported upbeat earnings for its fourth quarter, while sales missed estimates.